Acme Generics LLP

Acme Generics LLP - pharma in Chandigarh, India. Directors, charges & compliance details.
LLPIN AAD-5392 Incorporated 13 March 2015 ROC Chandigarh HQ Chandigarh, India
Converted to LLP Limited Liability Partnership pharma
Data last updated
Revenue · FY 2021
₹264.12 Cr
▲ 13% YoY
Net profit · FY 2021
₹19.51 Cr
Net margin 7.4%
EBITDA · FY 2021
₹43.84 Cr
EBITDA margin 16.6%
Contribution obligation
₹113.94 Cr
As per LLP agreement
Satisfied charges
₹15 Cr
No open charges
LLP age
11 yrs
Est. 2015
Designated partners
2
As per MCA filings
Active GSTINs
2
GST registered

About Acme Generics LLP

Data last updated:

Acme Generics LLP was a limited liability partnership (LLP) based in Chandigarh, India. The LLP has been converted into a company and no longer exists as an LLP. For the latest details, refer to the successor company. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 March 2015.

The LLP was registered with the Registrar of Companies (ROC), Chandigarh, under LLPIN AAD-5392. Its GSTIN is 02ABCFA2649A1Z9 (Himachal Pradesh). The LLP held 2 GST registrations, all of them active.

The LLP had a total obligation of contribution of ₹113.94 Cr. It was led by designated partners Ruby Shah and Viral Shah.

Its latest statement of accounts is for the year ended 31 March 2021. The registered office was at Plot No – 75 Industrial Area Phase – 1, Chandigarh, India – 160002.

As per the financials filed for FY 2021, the LLP reported a revenue of ₹264.12 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹19.51 Cr (net margin 7.4%) and EBITDA of ₹43.84 Cr (EBITDA margin 16.6%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 51% over five years.

The LLP is associated with 1 brand: Acme Generics. As per MCA filings, the LLP has satisfied charges of ₹15 Cr on record. Court records list 27 cases involving the LLP, including 21 filed by the LLP and 5 filed against it; 5 cases are pending.

The last known website on record is acmegenerics.in.

Company Details of Acme Generics LLP
LLPIN AAD-5392
Incorporation Date 13 March 2015
Total Obligation of Contribution ₹113.94 Cr
ROC Chandigarh
Company Status Converted to Company
Date of Last AGM 31 March 2021
Date of Balance Sheet 31 March 2021
Key People
Ruby Shah Designated Partner Viral Shah Designated Partner
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    acmegenerics.in
  • Social Media
  • Registered Address
    Plot No – 75 Industrial Area Phase – 1, Chandigarh, India – 160002
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Acme Generics LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Acme Generics LLP report

Financials, compliance, directors, charges, ownership and filings for Acme Generics LLP in one report.

Financials from 2015 Directors & ownership Charges & compliance

Associated Brands with Acme Generics LLP

Acme Generics operates one associated brand: Acme Generics. Each brand links to its own profile.

BrandDescriptionWebsite
Acme Generics
Solid and liquid formulations are manufactured as a CDMO focus.acmegenerics.in

Competitors & Alternatives of Acme Generics LLP

Brands and companies operating in the same space as Acme Generics LLP include Abzena, Syngene, Grand River Aseptic Manufacturing and 6 more.

CompetitorDescriptionLocationFounded
Abzena Abzena Provider of antibody discovery, cell line development, and bio analytics servicesCambridge, United Kingdom2001
Syngene Syngene Provider of contract research and manufacturing services for both small molecules and biologicsBengaluru, India1993
Grand River Aseptic Manufacturing Grand River Aseptic Manufacturing Sterile parenteral CDMO services for development and manufacturing are offered.Grand Rapids, United States2010
Patheon Patheon Commercial manufacturing and pharmaceutical development services for biopharmaceutical industryDurham, United States1974
Panacea Biotec Panacea Biotec Developer of biosimilars, vaccines and natural productsAmbala, India1984
Piramal Group Piramal Group Multinational conglomerate with diverse interests in Pharma, Financial Services and Real EstateMumbai, India1984
Maravai Life Sciences Maravai Life Sciences Provides enabling tools and services in the life sciences research and bio-production industriesSan Diego, United States2014
LakePharma LakePharma Provider of drug discovery on molecular biology, viral vectors and cell & protein engineeringBelmont, United States2009
Insud Pharma Insud Pharma Finished formulations, APIs, and monoclonal antibodies are developed and manufactured.Madrid, Spain1977

Auditor Details of Acme Generics LLP

Acme Generics LLP is audited by VINOD KUMAR & ASSOCIATES for the financial year 2021.

NameStatusAppointment DateCessation Date
VINOD KUMAR & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Designated Partners of Acme Generics LLP

Acme Generics has 2 current designated partners and 5 former designated partners. Current designated partners are listed first, with their designation and appointment date.

Designated Partners (as last reported)
NameDesignationAppointment DateTenureStatus
Ruby Shah
Also directs: Ambriel Life Sciences LLP, Tekno Touch Private Limited
Designated Partner01 Apr 20215 Years 6 MonthsAs last reported
Viral Shah
Also directs: Ambriel Life Sciences LLP, Acme Generics Private Limited, Acme Formulation Private Limited and 4 more
Designated Partner01 Apr 20215 Years 6 MonthsAs last reported
View all designated partners

Financials of Acme Generics LLP FY 2021 filings available

Acme Generics LLP reported revenue of ₹264.12 Cr (up 13% YoY) for FY 2021.

Revenue · FY 2021
₹264.12 Cr ▲ 13%
Net profit · FY 2021
₹19.51 Cr margin 7.4%
EBITDA · FY 2021
₹43.84 Cr margin 16.6%

Compounded Annual Growth Rate (CAGR) of Acme Generics LLP

Revenue CAGR growth
1 year
▲ 13%
3 years · compounded
▲ 1%
5 years · compounded
▲ 51%
EBITDA CAGR growth
1 year
▲ 49%

Revenue has grown at a compounded annual rate (CAGR) of 51% over five years, including 13% growth in the latest year. EBITDA rose 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Acme Generics LLP

Statement of Account and SolvencyFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Income and Expenditure
Turnover••••••••••••••••••••
Other Income••••••••••••••••••••
Total Income₹264.12 Cr••••••••••••••••
Purchases and Direct Costs••••••••••••••••••••
Personnel Expenses••••••••••••••••••••
Administrative Expenses••••••••••••••••••••
Interest••••••••••••••••••••
Depreciation••••••••••••••••••••
Total Expenses••••••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax••••••••••••••••••••
Profit After Tax₹19.51 Cr••••••••••••••••
Profit Transferred to Partners••••••••••••••••••••
Assets and Liabilities
Partners' Contribution••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Secured Loans••••••••••••••••••••
Unsecured Loans••••••••••••••••••••
Trade Payables••••••••••••••••••••
Other Liabilities and Provisions••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Loans and Advances••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Acme Generics LLP

Statement of Account and SolvencyFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profitability
Net Profit Margin7.4%••••••••••••••••
Return on Partners' Funds••••••••••••••••••••
Return on Assets••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Debt to Partners' Funds••••••••••••••••••••
Interest Coverage••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Turnover Growth••••••••••••••••••••
Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Acme Generics are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Acme Generics LLP

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Acme Generics LLP

Open charges
None
Satisfied charges
₹15 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹15.00 Cr
Latest charge details
DateLenderAmountStatus
18 Dec 2018Hdfc Bank Limited₹15 CrSatisfied

Total charge records: 1 View all charges

Employees and EPFO Compliance at Acme Generics LLP

Employment history and EPFO contributions of people linked to Acme Generics.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Acme Generics LLP

Acme Generics has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
02ABCFA2649A1Z9Himachal PradeshActive01 Jul 2017
29ABCFA2649A1ZTKarnatakaActive01 Jul 2018
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Acme Generics LLP

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Acme Generics LLP

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Acme Generics LLP

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Acme Generics LLP

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Acme Generics LLP

Charges
07 Jul 2021
A charge registered on 18 Dec 2018 via Charge ID 100240124 with Hdfc Bank Limited was fully satisfied on 07 Jul 2021.
Directors
01 Apr 2021
Ruby Shah was appointed as a Designated Partner on 01 Apr 2021 & has been associated with this company since 5 years 6 months.
Directors
01 Apr 2021
Viral Shah was appointed as a Designated Partner on 01 Apr 2021 & has been associated with this company since 5 years 6 months.
Activity
31 Mar 2021
Acme Generics Llp last Annual general meeting of members was held on 31 Mar 2021 as per latest MCA records.
Activity
31 Mar 2021
Acme Generics Llp has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Chandigarh.
Charges
18 Dec 2018
A charge with Hdfc Bank Limited amounted to Rs. 15.00 Cr with Charge ID 100240124 was registered on 18 Dec 2018.

Frequently Asked Questions about Acme Generics LLP

Acme Generics has been converted into a company - the business changed its legal structure from a Limited Liability Partnership to a company. The LLP no longer exists in its previous form. For the latest information, refer to the successor company registered with MCA.

Acme Generics was a limited liability partnership based in Chandigarh, India. The LLP worked in drug formulation and development, within the pharma industry. It was incorporated on 13 March 2015 and is registered under LLPIN AAD-5392. For the latest details, refer to the successor company.

The LLPIN (Limited Liability Partnership Identification Number) of Acme Generics is AAD-5392. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Acme Generics had 2 designated partners:

Acme Generics was incorporated on 13 March 2015. It is registered with the Registrar of Companies, Chandigarh.

Acme Generics can be reached through the website acmegenerics.in. Its registered office is in Chandigarh, India.

The registered office of Acme Generics is at Plot No – 75 Industrial Area Phase – 1, Chandigarh, India – 160002.

Acme Generics reported revenue of ₹264.12 Cr for FY 2021 (up 13% YoY).

The total obligation of contribution is ₹113.94 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available